In ANCA-associated vasculitis, excessive inflammatory reactions lead to pulmonary hemorrhages that can be fatal if left untreated. Researchers have deciphered a mechanism in mice and patients that ...

Bacterial DNA Motifs Trigger ANCA Production in ANCA-Associated Vasculitis in Remission Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CG, Heeringa P Rheumatology (Oxford). 2011;50:689-696 ...

Despite a stable incidence of ANCA-associated vasculitis in southern Sweden, the prevalence of the condition has increased, according to a population-based study spanning a 23-year period. From ...

Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis is a systemic condition affecting the small vessels with production of MPO-ANCA in serum. It has been suggested ...

Vasculitis can be classified into several types based on the size of the blood vessels affected and the underlying cause. ANCA-Associated Vasculitis This includes granulomatosis with polyangiitis ...

The Kidney Disease: Improving Global Outcomes organization has published a new guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The 46-page ...

Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function status is strongly predictive of outcomes 1 year later, according to ...

JAK Inhibitor Succeeds in Refractory Vasculitis — Seven of 11 patients respond after failing multiple previous meds by John Gever, Contributing Writer, MedPage Today March 16, 2023 ...

Study Results Median follow-up was 4.1 years from study entry. Throughout the study, 5 of 58 patients in the B-cell arm and 14 of 57 in the ANCA arm had relapses. According to Kaplan-Meier ...

SAN DIEGO — Approximately two-thirds of patients with ANCA-associated vasculitis report having neurological involvement, according to data presented at ACR Convergence 2023.“Most data on ...

New findings from a Japanese study suggest a possible link between COVID-19 mRNA vaccination and ANCA-associated vasculitis (AAV). From February 2021 to February 2023, Japan successfully completed ...